Drug profile · INN
insulin glargine-aldy
LANGLARA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
insulin glargine-aldy (LANGLARA) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN insulin glargine-aldy
Brand LANGLARA
Route SUBCUTANEOUS
Formulation INJECTABLE
Originator Sunshine Biopharma
Frequently asked questions
What is insulin glargine-aldy?
insulin glargine-aldy (LANGLARA) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for insulin glargine-aldy?
LANGLARA is a marketed brand name for insulin glargine-aldy. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin glargine-aldy?
insulin glargine-aldy has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.